Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper

The ubiquitous, early‐stage expression, efficient internalization, limited off‐target effects, and high disease specificity of CD19 make it an attractive therapeutic target. Currently available anti‐CD19 therapies have demonstrated particular promise in patients with relapsed or refractory B‐cell no...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly, Sarah, Cartron, Guillaume, Chaganti, Sridhar, Córdoba, Raul, Corradini, Paolo, Düll, Johannes, Ferrarini, Isacco, Osborne, Wendy, Rosenwald, Andreas, Sancho, Juan‐Manuel, Tilly, Hervé, Van Den Neste, Eric, Viardot, Andreas, Visco, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796473/
https://www.ncbi.nlm.nih.gov/pubmed/35488888
http://dx.doi.org/10.1002/hon.3013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796473/
https://www.ncbi.nlm.nih.gov/pubmed/35488888
http://dx.doi.org/10.1002/hon.3013

Ejemplares similares